Geron Corp. (GERN)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

919 EAST HILLSDALE BOULEVARD FOSTER CITY, CA 94404

Geron Corp. focuses on on developing and commercializing therapeutic and diagnostic products for cancer based on its telomerase technology, and cell-based therapeutics using its human embryonic stem cell technology.

Data as of 2021-05-08 10:17:09 -0400
Market Cap423.646 Million Shares Outstanding318.531 Million Avg 30-day Volume1.87 Million
P/E Ratio-5.60252 Dividend Yield EPS-0.279
Price/Sales1674.49 Debt to Equity1.28 EBITDA-76.755 Million
Price to Book Value2.01 Forward PE-3.93 Enterprise Value251.413 Million
Total Cash196.275 Million Current Debt30.94 Million Gross Profit253 Thousand
BETA1.1295 52-week High/Low2.4 / 1.28 Next Earnings Date Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from GERN instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 0 0 (0.0%) 0 (0.0%)
Funds Holding: 152 152 0.0% 35 (2.1%) 34 (2.12%) 2.94%
13F shares: 175.398 Million 172.345 Million 1.77% 87.107 Million 85.904 Million 1.4%
% Ownership 56.494 55.5105 1.77% 28.0564 27.6687 1.4%
New Positions: 16 27 -40.74% 1 11 -90.91%
Increased Positions 54 55 -1.82% 16 7 128.57%
Closed Positions 14 13 7.69% 6
Reduced Positions 36 23 56.52% 9 8 12.5%
Total Calls 1.913 Million 1.593 Million 20.03% 306.9 Thousand 201.4 Thousand 52.38%
Total Puts 580.822 Thousand 609.711 Thousand -4.74% 75.9 Thousand 69.9 Thousand 8.58%
PUT/CALL Ratio 0.3 0.38 -21.05% 0.25 0.35 -28.57%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding GERN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding GERN BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SPIEGEL ROBERT J.

  • Director
119,497 2021-03-31 5

SCARLETT JOHN A CHAIRMAN, PRESIDENT AND CEO

  • Officer
  • Director
0 2021-02-02 1

ROSENFIELD STEPHEN EVP, CHIEF LEGAL OFF & SEC

  • Officer
0 2021-02-02 1

BEHRS MELISSA KELLY EVP, CHIEF BUSINESS OFFICER

  • Officer
0 2021-02-02 1

BLOOM OLIVIA KYUSUK EVP, CHIEF FINANCIAL OFFICER

  • Officer
0 2021-02-02 1

GRETHLEIN ANDREW J EVP, CHIEF OPERATING OFFICER

  • Officer
0 2021-02-02 1

RIZO ALEKSANDRA EVP, CHIEF MEDICAL OFFICER

  • Officer
0 2021-02-02 1

KAPUR ANIL EVP, CORP STRATEGY & CCO

  • Officer
0 2021-02-02 1

O'FARRELL ELIZABETH G.

  • Director
19,641 2020-08-21 2

LAWLIS V BRYAN

  • Director
0 2020-06-05 1

EASTHAM KARIN

  • Director
0 2020-06-05 1

MOLINEAUX SUSAN

  • Director
0 2020-06-05 1

BIR DAWN CARTER

  • Director
0 2020-06-05 1

BRADBURY DANIEL

  • Director
51,323 2019-03-29 0

HUH HOYOUNG

  • Director
0 2018-05-15 0

HOFSTAETTER THOMAS

  • Director
26,564 2015-03-18 0

PARKER CRAIG C EVP, CORP DEV & SCI AFFAIRS

  • Officer
0 2014-02-10 0

KILEY THOMAS

  • Director
No longer subject to file 2013-05-22 0

FRITZKY EDWARD V

  • Director
No longer subject to file 2013-05-22 0

KELSEY STEPHEN MICHAEL EVP, R&D, CHIEF MED OFFICER

  • Officer
No longer subject to file 2013-05-03 0

EARP DAVID SVP, CORP TRANSACTIONS

  • Officer
467,406 2012-06-01 0

COOPER GRAHAM K EVP, BUS DEV & CFO

  • Officer
0 2012-05-17 0

GREENWOOD DAVID PRESIDENT, INTERIM CEO, CFO

  • Officer
  • Director
754,031 2011-06-14 0

LEBKOWSKI JANE SVP, CHIEF SCIENTIFIC OFFICER

  • Officer
568,154 2011-06-14 0

SPINK KATHARINE E. SVP ALLIANCE MGMT & OPERATIONS

  • Officer
328,561 2011-06-14 0

BARKAS ALEXANDER E

  • Director
353,122 2011-05-20 0

NALLICHERI MELANIE I SVP CORP DEV

  • Officer
195,000 2011-05-20 0

HOMCY CHARLES J

  • Director
No longer subject to file 2011-05-11 0

OKARMA THOMAS PRESIDENT AND CEO

  • Officer
774,560 2010-07-09 0

ZENNER PATRICK J

  • Director
No longer subject to file 2010-05-19 0

HARLEY CALVIN VP, CSO TELOMERASE TECH

  • Officer
134,036 2009-05-29 0

BENEDETTI FABIO M SVP, CHIEF MED OFF, ONCOLOGY

  • Officer
80,560 2009-05-29 0

WALKER JOHN PETER

  • Director
No longer subject to file 2009-01-30 0

COLOWICK ALAN PRESIDENT, ONCOLOGY

  • Officer
3,028 2008-01-02 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

SPIEGEL ROBERT J. - Director

2021-04-02 17:06:46 -0400 2021-03-31 A 4,549 a 119,497 direct -0.625 -11.25 0.0 1 -11.25 6

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
GERON CORP GERN 2021-05-10 21:45:02 UTC -0.3971 0.4471 1100000
GERON CORP GERN 2021-05-10 21:15:02 UTC -0.3971 0.4471 1100000
GERON CORP GERN 2021-05-10 20:45:03 UTC -0.3971 0.4471 1100000
GERON CORP GERN 2021-05-10 20:15:03 UTC -0.3971 0.4471 1100000
GERON CORP GERN 2021-05-10 19:45:03 UTC -0.3971 0.4471 1100000
GERON CORP GERN 2021-05-10 19:15:03 UTC -0.3971 0.4471 1100000
GERON CORP GERN 2021-05-10 18:45:03 UTC -0.3971 0.4471 1100000
GERON CORP GERN 2021-05-10 18:15:03 UTC -0.3971 0.4471 1100000
GERON CORP GERN 2021-05-10 17:45:02 UTC -0.3971 0.4471 1100000
GERON CORP GERN 2021-05-10 17:15:03 UTC -0.3971 0.4471 1100000
GERON CORP GERN 2021-05-10 16:45:03 UTC -0.4054 0.4554 1100000
GERON CORP GERN 2021-05-10 16:15:03 UTC -0.4054 0.4554 1100000
GERON CORP GERN 2021-05-10 15:45:03 UTC -0.4054 0.4554 1100000
GERON CORP GERN 2021-05-10 15:15:03 UTC -0.4054 0.4554 1100000
GERON CORP GERN 2021-05-10 14:45:04 UTC -0.4058 0.4558 1100000
GERON CORP GERN 2021-05-10 14:15:04 UTC -0.4058 0.4558 1100000
GERON CORP GERN 2021-05-10 13:45:04 UTC -0.4058 0.4558 900000
GERON CORP GERN 2021-05-10 13:15:03 UTC -0.4058 0.4558 900000
GERON CORP GERN 2021-05-10 12:45:02 UTC -0.4058 0.4558 900000
GERON CORP GERN 2021-05-07 22:15:03 UTC -0.4058 0.4558 1100000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
RUSSELL INVESTMENT CO- U.S. Small Cap Equity Fund GERN -88688.0 shares, $-154317.12 2020-10-31 N-PORT
RUSSELL INVESTMENT FUNDS- U.S. Small Cap Equity Fund GERN -12435.0 shares, $-19771.65 2020-12-31 N-PORT

Elevate your investments